Mechanisms for Insulin Resistance: Common Threads and Missing Links
暂无分享,去创建一个
[1] R. Kaufman,et al. The unfolded protein response , 2003, Journal of Cell Science.
[2] S. Burgess,et al. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. , 2011, Cell metabolism.
[3] G. Shulman,et al. Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice* , 2011, The Journal of Biological Chemistry.
[4] Xianlin Han,et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease , 2011, Proceedings of the National Academy of Sciences.
[5] K. Petersen,et al. Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance , 2011, Hepatology.
[6] G. Shulman,et al. Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism , 2011, The Journal of Biological Chemistry.
[7] An-fang Cui,et al. Mouse patatin‐like phospholipase domain‐containing 3 influences systemic lipid and glucose homeostasis , 2011, Hepatology.
[8] F. Alvarez,et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis , 2011, Hepatology.
[9] J. Girard,et al. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. , 2011, Journal of hepatology.
[10] Benjamin S. Aribisala,et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol , 2011, Diabetologia.
[11] G. Shulman,et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. , 2011, Cell metabolism.
[12] C. Kahn,et al. PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. , 2011, The Journal of clinical investigation.
[13] G. Schmitz,et al. Altered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in Humans , 2011, Diabetes.
[14] L. Glimcher,et al. Dual and opposing roles of the unfolded protein response regulated by IRE1α and XBP1 in proinsulin processing and insulin secretion , 2011, Proceedings of the National Academy of Sciences.
[15] D. Clegg,et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. , 2011, The Journal of clinical investigation.
[16] A. Bennett,et al. Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC)/Fat-specific Protein 27* , 2011, The Journal of Biological Chemistry.
[17] P. Meikle,et al. Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase , 2011, Diabetes.
[18] Kezhong Zhang,et al. The unfolded protein response transducer IRE1α prevents ER stress‐induced hepatic steatosis , 2011, EMBO Journal.
[19] K. Brownell,et al. Taxation as prevention and as a treatment for obesity: the case of sugar-sweetened beverages. , 2011, Current pharmaceutical design.
[20] G. Shulman,et al. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 , 2011, Proceedings of the National Academy of Sciences.
[21] M. Raftery,et al. Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice , 2011, Diabetologia.
[22] M. Patti,et al. The chemical chaperones tauroursodeoxycholic and 4‐phenylbutyric acid accelerate thyroid hormone activation and energy expenditure , 2011, FEBS letters.
[23] Jonathan C. Cohen,et al. Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance , 2011, Hepatology.
[24] M. Kumari,et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome[S] , 2011, Journal of Lipid Research.
[25] A. Chawla,et al. Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes[S] , 2011, Journal of Lipid Research.
[26] A. Lin,et al. Selective Inactivation of c-Jun NH2-Terminal Kinase in Adipose Tissue Protects Against Diet-Induced Obesity and Improves Insulin Sensitivity in Both Liver and Skeletal Muscle in Mice , 2011, Diabetes.
[27] Ewald Moser,et al. Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes , 2011, Diabetes Care.
[28] Jouhyun Jeon,et al. Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice , 2010, PloS one.
[29] R. DeFronzo,et al. NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions. , 2010, American journal of physiology. Endocrinology and metabolism.
[30] John T. Melchior,et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance[S] , 2010, Journal of Lipid Research.
[31] B. Pedersen,et al. IL-6 selectively stimulates fat metabolism in human skeletal muscle. , 2010, American journal of physiology. Endocrinology and metabolism.
[32] A. Hevener,et al. Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. , 2010, Endocrinology.
[33] D. Williamson,et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.
[34] Hongyu Zhao,et al. A common variant in the patatin‐like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents , 2010, Hepatology.
[35] R. Zechner,et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. , 2010, The Journal of clinical investigation.
[36] B. Chang,et al. Patatin‐like phospholipase domain‐containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease , 2010, Hepatology.
[37] Cameron D. Palmer,et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease , 2010, Hepatology.
[38] A. Harada,et al. Induction of Liver Steatosis and Lipid Droplet Formation in ATF6α-Knockout Mice Burdened with Pharmacological Endoplasmic Reticulum Stress , 2010, Molecular biology of the cell.
[39] M. Kay,et al. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. , 2010, American journal of physiology. Endocrinology and metabolism.
[40] William O Richards,et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. , 2010, Gastroenterology.
[41] P. Schrauwen,et al. Prolonged Fasting Identifies Skeletal Muscle Mitochondrial Dysfunction as Consequence Rather Than Cause of Human Insulin Resistance , 2010, Diabetes.
[42] D. Muoio,et al. Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption , 2010, Diabetes.
[43] B. S. Mohammed,et al. Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women , 2010, Diabetes.
[44] Jonathan C. Cohen,et al. A feed-forward loop amplifies nutritional regulation of PNPLA3 , 2010, Proceedings of the National Academy of Sciences.
[45] Young-sil Yoon,et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. , 2010, Cell metabolism.
[46] Xin Lu,et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. , 2010, Cell metabolism.
[47] M. White,et al. Irs1 serine 307 promotes insulin sensitivity in mice. , 2010, Cell metabolism.
[48] L. N. Valenti,et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.
[49] M. Watt,et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice , 2010, Diabetologia.
[50] Nick V. Grishin,et al. A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.
[51] Jianping Ye,et al. Uncoupling of Inflammation and Insulin Resistance by NF-κB in Transgenic Mice through Elevated Energy Expenditure* , 2009, The Journal of Biological Chemistry.
[52] M. Birnbaum,et al. The immune response attenuates growth and nutrient storage in Drosophila by reducing insulin signaling , 2009, Proceedings of the National Academy of Sciences.
[53] P. Ferré,et al. Plasma Membrane Subdomain Compartmentalization Contributes to Distinct Mechanisms of Ceramide Action on Insulin Signaling , 2009, Diabetes.
[54] A. Mora,et al. Prevention of steatosis by hepatic JNK1. , 2009, Cell metabolism.
[55] Jason K. Kim,et al. Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance , 2009, Molecular and Cellular Biology.
[56] G. Cooney,et al. Diverse roles for protein kinase C δ and protein kinase C ε in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C δ , 2009, Diabetologia.
[57] Risheng Ye,et al. Grp78 Heterozygosity Promotes Adaptive Unfolded Protein Response and Attenuates Diet-Induced Obesity and Insulin Resistance , 2009, Diabetes.
[58] D. Langin,et al. Chronic TNFα and cAMP pre‐treatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis , 2009, FEBS letters.
[59] B. S. Mohammed,et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.
[60] F. Schick,et al. Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.
[61] R. Zechner,et al. Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[62] K. Ikeda,et al. Molecular Cloning and Expression of Starfish Protein Kinase C Isoforms , 2009, Bioscience, biotechnology, and biochemistry.
[63] Xinmin Zhang,et al. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. , 2009, Cell metabolism.
[64] M. Lazar,et al. Endoplasmic Reticulum Stress Regulates Adipocyte Resistin Expression , 2009, Diabetes.
[65] S. Luquet,et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. , 2009, The Journal of clinical investigation.
[66] B. S. Mohammed,et al. Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.
[67] Robert V Farese,et al. The Endoplasmic Reticulum Enzyme DGAT2 Is Found in Mitochondria-associated Membranes and Has a Mitochondrial Targeting Signal That Promotes Its Association with Mitochondria* , 2009, Journal of Biological Chemistry.
[68] M. Ridderstråle,et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans , 2009, Diabetologia.
[69] G. Shulman,et al. Adipose Overexpression of Desnutrin Promotes Fatty Acid Use and Attenuates Diet-Induced Obesity , 2009, Diabetes.
[70] Gangyi Yang,et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. , 2009, Cytokine.
[71] A. Mora,et al. A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.
[72] R. Eckel,et al. Skeletal Muscle–Specific Deletion of Lipoprotein Lipase Enhances Insulin Signaling in Skeletal Muscle but Causes Insulin Resistance in Liver and Other Tissues , 2008, Diabetes.
[73] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[74] Theresa A. Storm,et al. Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia* , 2008, Journal of Biological Chemistry.
[75] L. Glimcher,et al. Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.
[76] D. Ron,et al. Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. , 2008, Cell metabolism.
[77] S. Crawford,et al. Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). , 2008, Journal of hepatology.
[78] M. Laakso,et al. Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance , 2008, Cell.
[79] J. Romijn,et al. Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. , 2008, The Journal of clinical endocrinology and metabolism.
[80] T. Luedde,et al. Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis , 2008, Proceedings of the National Academy of Sciences.
[81] Robert V Farese,et al. Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[82] J. Dyck,et al. Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity , 2007, Diabetes.
[83] G. Shulman,et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[84] G. Shulman,et al. Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance* , 2007, Journal of Biological Chemistry.
[85] Robert V Farese,et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. , 2007, Cell metabolism.
[86] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[87] Yiying Zhang,et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.
[88] Shuli Wang,et al. Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance* , 2007, Journal of Biological Chemistry.
[89] P. Arner,et al. NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes. , 2007, Journal of lipid research.
[90] T. Fox,et al. Ceramide Recruits and Activates Protein Kinase C ζ (PKCζ) within Structured Membrane Microdomains* , 2007, Journal of Biological Chemistry.
[91] M. Birnbaum,et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.
[92] A. Palou,et al. Regulation of Adiponutrin Expression by Feeding Conditions in Rats Is Altered in the Obese State , 2007, Obesity.
[93] T. Luedde,et al. Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .
[94] E. Ravussin,et al. Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. , 2007, American journal of physiology. Endocrinology and metabolism.
[95] M. Kester,et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. , 2007, The Journal of biological chemistry.
[96] T. Luedde,et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.
[97] E. Ravussin,et al. Inactivation of PKCθ leads to increased susceptibility to obesity and dietary insulin resistance in mice , 2007 .
[98] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[99] E. Yilmaz,et al. Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.
[100] M. Karin,et al. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[101] P. Neufer,et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. , 2006, Cell metabolism.
[102] R. Kitazawa,et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.
[103] Ji Young Kim,et al. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARγ , 2006 .
[104] E. Wagner,et al. Defective Lipolysis and Altered Energy Metabolism in Mice Lacking Adipose Triglyceride Lipase , 2006, Science.
[105] Randal J. Kaufman,et al. Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response , 2006, Cell.
[106] R. Leibel,et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.
[107] Ji Young Kim,et al. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. , 2006, American journal of physiology. Endocrinology and metabolism.
[108] J. Flier,et al. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. , 2006, Diabetes.
[109] K. Gumireddy,et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. , 2005, Diabetes.
[110] L. E. Hammond,et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. , 2005, Cell metabolism.
[111] K. Petersen,et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.
[112] A. Hevener,et al. IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.
[113] R. Gross,et al. Identification, Cloning, Expression, and Purification of Three Novel Human Calcium-independent Phospholipase A2 Family Members Possessing Triacylglycerol Lipase and Acylglycerol Transacylase Activities* , 2004, Journal of Biological Chemistry.
[114] M. Birnbaum,et al. Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101* , 2004, Journal of Biological Chemistry.
[115] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[116] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[117] C. Bruce,et al. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. , 2004, American journal of physiology. Endocrinology and metabolism.
[118] Dan R. Littman,et al. PKC-θ knockout mice are protected from fat-induced insulin resistance , 2004 .
[119] F. Liu,et al. Regulation of Insulin Action by Ceramide , 2004, Journal of Biological Chemistry.
[120] H. Lodish,et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.
[121] Richard G. W. Anderson,et al. Chinese Hamster Ovary K2 Cell Lipid Droplets Appear to Be Metabolic Organelles Involved in Membrane Traffic* , 2004, Journal of Biological Chemistry.
[122] M. Birnbaum,et al. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). , 2004, The Journal of biological chemistry.
[123] G. Shulman,et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. , 2004, The Journal of clinical investigation.
[124] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[125] M. Febbraio,et al. Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion , 2004, Diabetologia.
[126] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[127] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[128] B. Teusink,et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300143-JLR200 , 2003, Journal of Lipid Research.
[129] É. Hajduch,et al. Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKCζ-Dependent Mechanism , 2003, Molecular and Cellular Biology.
[130] S. Liang,et al. PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth factor-I derived from the liver. , 2003, Endocrinology.
[131] G. Shulman,et al. Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.
[132] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[133] I. G. Fantus,et al. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ , 2002 .
[134] K. Mori,et al. Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. , 2002, The Biochemical journal.
[135] N. Ruderman,et al. Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .
[136] A. Bonen,et al. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.
[137] K. Petersen,et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.
[138] N. Ruderman,et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.
[139] I. G. Fantus,et al. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. , 2002, American journal of physiology. Endocrinology and metabolism.
[140] Simon C Watkins,et al. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. , 2001, The Journal of clinical endocrinology and metabolism.
[141] M. Lorenzo,et al. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. , 2001, Diabetes.
[142] G. Shulman,et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[143] G. Shulman,et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.
[144] Robert V Farese,et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.
[145] G. Shulman,et al. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.
[146] Roger Davis,et al. The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.
[147] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.
[148] D L Rothman,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13 C and 1 H Nuclear Magnetic Res , 1999 .
[149] M. Visser,et al. Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.
[150] H. Cortez‐Pinto,et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.
[151] C. Schmitz‐Peiffer,et al. Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate* , 1999, The Journal of Biological Chemistry.
[152] Z Trajanoski,et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.
[153] G. Shulman,et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.
[154] D L Rothman,et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.
[155] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[156] H. Radner,et al. Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. , 1998, The Journal of clinical investigation.
[157] M. A. Crook,et al. Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.
[158] A. Baron,et al. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.
[159] G. Shulman,et al. 13C and 31P NMR Studies on the Effects of Increased Plasma Free Fatty Acids on Intramuscular Glucose Metabolism in the Awake Rat* , 1997, The Journal of Biological Chemistry.
[160] R. Farese,et al. Chronic Activation of Protein Kinase C in Soleus Muscles and Other Tissues of Insulin-Resistant Type II diabetic Goto-Kakizaki (GK), Obese/Aged, and Obese/Zucker Rats: A Mechanism For Inhibiting Glycogen Synthesis , 1996, Diabetes.
[161] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[162] M. Pettermann,et al. Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. , 1996, The American journal of clinical nutrition.
[163] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[164] S. Mudaliar,et al. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. , 1995, The Journal of clinical investigation.
[165] K. Siddle,et al. Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered. , 1995, The Journal of clinical investigation.
[166] R. Considine,et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. , 1995, The Journal of clinical investigation.
[167] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[168] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[169] K. Siddle,et al. Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation. , 1994, The Biochemical journal.
[170] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[171] J. Olefsky,et al. Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors. , 1991, The Journal of biological chemistry.
[172] D. O'sullivan,et al. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. , 1990, The Journal of biological chemistry.
[173] C. Kahn,et al. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. , 1990, The Journal of biological chemistry.
[174] K. Siddle,et al. Phorbol ester-induced downregulation of protein kinase C potentiates insulin receptor tyrosine autophosphorylation: evidence for a major constitutive role in insulin receptor regulation. , 1990, Biochemical Society transactions.
[175] M. Czech,et al. Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. , 1990, Biochemistry.
[176] R G Shulman,et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.
[177] R. Wolfe,et al. Differentiation between septic and postburn insulin resistance. , 1989, Metabolism: clinical and experimental.
[178] H. Sasaki,et al. Insulin resistance in septic rats--a study by the euglycemic clamp technique. , 1989, Life sciences.
[179] C. Kahn,et al. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.
[180] M. Kawakami,et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.
[181] B. Obermaier,et al. Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. , 1986, The Journal of biological chemistry.
[182] P. Cuatrecasas,et al. Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[183] Raymond Rm,et al. Skeletal muscle insulin resistance during Escherichia coli bacteremic shock in the dog. , 1981 .
[184] T. Emerson,et al. Skeletal muscle insulin resistance during Escherichia coli bacteremic shock in the dog. , 1981, Surgery.
[185] E. Hirsch,et al. Blood insulin responses to blood glucose levels in high output sepsis and spetic shock. , 1978, American journal of surgery.
[186] J. D. Brown,et al. Effect of sodium salicylate on induced lipolysis in isolated fat cells of the rat. , 1969, Metabolism: clinical and experimental.
[187] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[188] P. J. Randle,et al. The glucose-fatty-acid cycle. , 1963, Lancet.